Bringing together manufacturers, regulators and payers to discuss developments impacting market entry, pricing and patient outcomes
Join the conversation about a changing pharma landscape at the Pathways to Access & Reimbursement Forum on June 16-17, 2020 in Toronto.
Top Reasons to Attend:
- Get direction on the latest changes to drug reviews and pricing ceilings to better inform market access and pricing strategies
- Gain insights on reimbursement regimes though Q & A with public and private payers
- Walk away with an understanding of how to bring innovative solutions to market
- Hear how other jurisdictions are approaching HTA and pricing negotiations
- Learn about developments in precision medicine that could increase the safety and efficacy of treatments while reducing healthcare spending
Past Attending Organizations Include:
- Sidley & Austin LLP
- Paladin Labs Inc
- Boehringer Ingelheim Canada Ltd
- Clinical Trials Ontario
- Sun Life Financial
- Green Shield Canada
- PIVINA Consulting Inc
- LifeLabs
- Amgen Canada Inc
- Pan-Canadian Pharmaceutical Alliance
- Canopy Growth Corporation
- Otsuka Canada Pharmaceutical Inc
- Norton Rose Fulbright Canada LLP
- GSK
- PMPRB
- Cancer Care Ontario
- Bristol Myers Squibb
- Cornerstone Research Group
- CADTH
- Novartis Canada
- Sandoz Canada Inc
- Innovative Medicines Canada
- Ipsen Biopharmaceuticals Canada
- Equitable Life of Canada
- SteriMax
- Brougham Consulting Inc
- Osler Hoskin & Harcourt LLP
- Canadian Organization for Rare Disorders
- Leslie Dan Faculty of Pharmacy
- GlaxoSmithKline Plc
- RWW Consultants
- PENDOPHARM
- AstraZeneca Canada Inc
- Innomar Strategies Inc
- AbbVie Corporation
- INESSS
- Great West Life
- Jamp Pharma Corporation
